Follow the link to Derek Low's In the Pipeline for a blog post of the same title today. In it, he highlights the balance that needs to be struck in reporting progress with difficult diseases like Parkinson's, Alzheimer's, etc and reporting that cures are imminent. There is often a large gap between medical science offering us a glimmer of hope in unraveling the next step toward a cure for one of these complex diseases and an actual clinical therapy - which can be years (or even decades off). You need to be responsible when reporting on progress to strike that proper balance.
However, I was struck by Derek's headline, and somewhat by the irony that this week's stem cell ruling will temporarily (hopefully) derail one promising avenue for the treatment of these disorders - namely stem cell therapies. Clearly, these are years off but constant political wrangling and start/stops to research are not particularly helpful in reaching a cure.
Where are the cures? Apparently not with stem cells for the moment as a result of Lamberth's ruling.
Posted by Bruce Lehr August 25th 2010.